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Inducible nitric oxide synthase (iNOS) is a main enzyme producing nitric oxide during inflammation and
thus contributes to the initiation and development of inflammatory cardiovascular diseases such as
atherosclerosis. Epigallocatechin-3-gallate (EGCG), the major catechin derived from green tea, has
multiple beneficial effects for treating cardiovascular disease, but the effect of EGCG on the expression of
vascular iNOS remains unknown. In this study, we investigated (i) whether EGCG inhibits the expression
of vascular iNOS induced by angiotensin II in human umbilical vein endothelial cells and, if it does
inhibit, (ii) mechanisms underlying the inhibition. Angiotensin II increased expression levels of vascular
iNOS; EGCG counteracted this effect. EGCG increased the production of reactive oxygen species.
Moreover, EGCG did not affect the production of reactive oxygen species induced by angiotensin II.
These data suggest a novel mechanism whereby EGCG provides direct vascular benefits for treating
inflammatory cardiovascular diseases.
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Atherosclerosis, which has been linked to abnormalities
in nitric oxide (NO) signaling, is a chronic systemic disease
of the vasculature with an inflammatory component. NO
is produced by nitric oxide synthase (NOS), which has three
isoforms: neuronal NOS (nNOS), endothelial NOS (eNOS),
and inducible NOS (iNOS) [1]. Both eNOS and nNOS are
constitutively expressed. In contrast, iNOS expression is
inducible by activated macrophages as an immune reaction.
During infection, iNOS produces large quantities of NO [2].
iNOS knockout mice decreased diet-induced atherosclerosis
[3]. apolipoprotein E (ApoE)/iNOS double knockout mice
showed significantly smaller atherosclerotic lesions compared
to ApoE knockout mice, suggesting that reduction in iNOS-
mediated oxidative stress may protect lesion formation in
double knockout mice [4].
Numerous studies have demonstrated that activation of
the angiotensin II type 1 (AT1) receptor plays an important
role in the pathogenesis of inflammatory diseases. AT1 receptor
blockers reduced lipopolysaccharide (LPS)-induced upregulation
of iNOS gene and protein expression and iNOS activity, which
decreased the general peripheral inflammatory reaction to
LPS [5]. LPS-stimulated glomerular iNOS expression was
enhanced in diabetic nephropathy, and the activation of
angiotensin II may play a role in this enhancement [6].
Olmesartan, a new AT1 receptor blocker, significantly
decreased the expression of iNOS in myocardial tissue with
a decrease in myocardial inflammation [7]. Losartan, an AT1
receptor blocker, reduced iNOS expression and reestablished
the redox status, thus reducing early markers of diabetic
retinopathy in a model of diabetes and hypertension [8].
Flavonoids are polyphenolic compounds that are widely
distributed in plants, and their consumption might be
associated with decreased risks for some chronic degenerative
diseases in humans [9]. Epidemiological research in Japan
has shown that green tea consumption protects against
coronary atherosclerosis [10]. Recent evidence has shown
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that interleukin-1β (IL-1β)-induced expression of iNOS was
markedly inhibited in human chondrocytes pretreated with
epigallocatechin-3-gallate (EGCG), a flavanol that is enriched
in green tea [11]. EGCG reduced IL-1β and interferon-γ (IFN-
γ)-induced NO production, and reduced levels of iNOS mRNA
and iNOS protein in RINm5F cells [12]. Ex vivo analysis of
β-islets showed that EGCG down-regulates expression of iNOS
[13] induced by multiple low doses of streptozotocin. EGCG
inhibited effects induced by ultraviolet B (UVB) including
activation and translocation of NF-κB, expression of iNOS
mRNA and generation of NO, indicating that EGCG protects
against UVB-induced skin damage [14]. However, the effect
of EGCG on the expression of iNOS, a major risk factor
for vascular inflammation, remains unknown. Accordingly, we
investigated this knowledge gap using human umbilical vein
endothelial cells (HUVECs). This could be clinically important
because specific inhibitors of iNOS expression (such as EGCG)
might be helpful for the treatment of cardiovascular diseases
such as atherosclerosis. We hypothesized that EGCG reduces
the expression of iNOS and reactive oxygen species (ROS)
that is induced by angiotensin II in HUVECs.
Materials and Methods
Materials
All antibodies for Western blotting were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). The culture
medium was obtained from Invitrogen (Carlsbad, CA, USA).
Angiotensin II, EGCG and other reagents were purchased
from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise
specified.
Cell culture
HUVECs were obtained from Clonetics (Walkersville, MD,
USA). They were grown in medium 199 containing 0.1 mg/
mL heparin, 25 µg/mL endothelial cell growth factor (Biomedical
Technologies, Stoughton, MA, USA), 2 mM L-glutamine, 100
U/mL penicillin G, 100 µg/mL streptomycin and 20% fetal
bovine serum (FBS). The medium was renewed every two
days until confluence, when cells were subcultured at a 1:3
ratio and then cultured in an atmosphere of 95% air and
5% CO2 at 37
oC.
Western blot analysis
HUVEC cultures were starved for 12 h and treated with
the desired drugs for the desired times. Cells were lysed in
ice-cold buffer (20 mM Tris-HCl pH 7.4, 1% Triton X-100,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium
pyrophosphate, 1 mM β-glycerol phosphate, 1 mM Na3VO4,
1 mM PMSF and 1 µg/mL leupeptin). The lysates were
sonicated and centrifuged (12,000 rpm, 20 min). The protein
concentration was measured by the Bradford method. Equal
amounts of protein (10 µg) were run on 12% SDS-PAGE
and blotted onto polyvinylidene difluoride membranes. These
were incubated with rabbit polyclonal antibodies (1:100)
against iNOS. Secondary anti-rabbit antibodies and enhanced
chemiluminescence (ECL) Plus reagent kits (Amersham, Little
Chalfont, Buckinghamshire, UK) were used for detection.
Membranes were subsequently exposed to ECL hyperfilms.
Detection of ROS
Cells were starved in phenol red-free M199 medium
containing 1% FBS for 12 h and stimulated with angiotensin
II and 2’,7’-dichlorofluorescein diacetate for 2 h. Fluorescence
signals were quantified (Molecular Devices, Sunnyvale, CA,
USA).
Statistical analysis
Results are shown as the means±SEM from at least three
independent experiments. Statistical significance between the
means was assessed by one-way ANOVA followed by Tukey’s
multiple comparison test; P<0.05 was taken as statistically
significant.
Results
Angiotensin  II  increased  the  levels  of  iNOS  in
HUVECs
To determine whether expression of iNOS, a risk factor
for vascular inflammation, is affected by angiotensin II, HUVECs
were treated with angiotensin II. Angiotensin II (100 nM)
increased the expression of iNOS in a time-dependent manner
(Figure 1) causing iNOS levels to increase for the next 24
h. Thus, angiotensin II increases protein levels of vascular
endothelial iNOS.
Effect of EGCG on the expression of iNOS induced
by angiotensin II in HUVECs
To determine whether angiotensin II-stimulated iNOS
expression is affected by EGCG, HUVECs were pretreated
for 0.5 h with 10, 30, 50 µM EGCG prior to treatment with
angiotensin II (100 nM) for 24 h. Increasing concentrations
of EGCG inhibited Ang II-induced iNOS expression (Figure
2) Thus, EGCG, a major catechin obtained from green tea
leaf, decreases the protein level of iNOS in a concentration-
dependent manner.EGCG regulates iNOS expression in HUVECs 87
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Effect of EGCG on the production of ROS in HUVECs
To determine whether ROS production is affected by EGCG,
HUVECs were pretreated with EGCG. EGCG (10, 30 and
50 µM) increased ROS production compared with control
(no treatment), (Figure 3A). Angiotensin II (100 nM) increased
ROS production compared with control and this was not
prevented by 30 or 50 µM EGCG (Figure 3B). These data
suggest that EGCG decreases the protein level of iNOS without
affecting ROS.
Discussion
Inflammation is an important event in the development
of vascular diseases such as hypertension, atherosclerosis, and
restenosis [15]. Recent knockout studies on iNOS have clarified
the role of NO in inflammatory responses [16]. Plasma levels
of the proinflammatory cytokines tumour necrosis factor-α
(TNF-α), IL-6, and IL-1β were also significantly reduced in
iNOS-knockout mice in comparison with control wild-type
mice [17]. Expression of iNOS in the endothelium may be
a more important mediator of vascular dysfunction than
expression of iNOS in the adventitia [18]. Excess NO resulting
from iNOS activation was important in modulating vascular
permeability during sepsis [19]. iNOS was partially responsible
for pulmonary oxidative and nitrosative stress reactions in
a murine model [20]. A selective iNOS inhibitor, ONO1714,
retarded the development of atherosclerosis [21] induced by
a high-cholesterol diet. Increased iNOS activity was found
in circulating neutrophils of septic shock patients compared
to healthy volunteers [22].
Angiotensin II, a peptide hormone, also plays an important
role in atherosclerosis. Ang II, through activation of NF-κB-
mediated pro-inflammatory genes, promoted vascular
inflammation, leading to acceleration of atherosclerosis [23].
Inhibition of NF-κB by the antioxidant pyrrolidine
dithiocarbamate (PDTC) markedly reduced inflammation and
iNOS expression in a double transgenic rat model, in which
rats transgenic for the human angiotensinogen and renin genes
are crossed [24]. Angiotensin II via AT1 receptor increased
the accumulation of neutrophils and iNOS expression and
played a significant role in mediating inflammation in gastric
mucosa exposed to ischemia-reperfusion [25]. Irbesartan, an
AT1 receptor antagonist, attenuated atherosclerosis. This effect
was partly related to the inhibition of oxidative stress and
inflammatory signal transduction pathways in high cholesterol-
diet ApoE knockout mice [26]. Increased formation of
angiotensin II and iNOS in infiltrated macrophages and medial
smooth muscle cells (SMCs) might play important roles in
the development and progression of human coronary
atherosclerosis [27].
Catechin, a flavanol derived from green tea, possesses
antioxidant, antiangiogenesis and antiproliferation activities
during the prevention and treatment of cardiovascular diseases
[28]. EGCG decreased the risk of cardiovascular disease by
reducing inflammatory markers in rats fed an atherogenic
diet [29]. In the EGCG groups, iNOS expression was reduced
in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-
treated mice [30]. EGCG activated an adenosine 5'-
monophosphate-activated protein kinase and blocked LPS/
IFN-γ-induced iNOS expression, supernatant NO and IL-6
in mesangial cells from MRL/lpr lupus-like mice [31].
Pretreatment of NHBE cells with EGCG resulted in a significant
down-regulation of NF-κB-regulated proteins such as cyclin
D1, matrix metalloproteinase-9 (MMP-9), IL-8 and iNOS [32].
In the ventral prostate, EGCG significantly reduced cell
proliferation, induced apoptosis, and decreased androgen
receptors, insulin-like growth factor-1 (IGF-1), IGF-1 receptor,
phospho-extracellular signal-regulated kinases 1 and 2,
cyclooxygenase-2 (COX-2), and iNOS [33]. Administration
of EGCG significantly suppressed iNOS transgene induction
by IFN-γ and LPS [34].
In this study, we investigated whether EGCG reduces
angiotensin II-mediated iNOS expression in HUVECs.
Angiotensin II increased the levels of iNOS (Figure 1). EGCG
prevented the iNOS expression induced by angiotensin II
in a concentration-dependent manner (Figure 2). This novel
finding for the effects of green tea/EGCG is complemented
by findings that resveratrol, an important antioxidant found
in grapes and wine, diminished IFN-γ-induced levels of iNOS
protein, attenuated iNOS mRNA levels, and inhibited IFN-
Figure 1. Effect of angiotensin II (Ang II) treatment (100 nM, 0-
24 h) on the expression levels of inducible nitric oxide synthase
(iNOS) in human umbilical vein endothelial cells. Summary
data are shown as the mean±SEM.88 Hee Yul Ahn and Chan Hyung Kim
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γ-induced promoter activity of the iNOS gene [35]. Resveratrol
inhibited NO production by NO scavenging and down-
regulation of iNOS expression in RAW 264.7 cells [36].
Moreover, quercetin, a dietary flavonoid, decreased mRNA
expression of inducible enzymes such as COX-2 and iNOS,
and thus has protective effects against the oxidized low-density
lipoproteins (ox-LDL) induced inflammation in peripheral
blood mononuclear cells [37]. Quercetin inhibited myocardial
ischemia-reperfusion-induced iNOS mRNA and protein
expression in rabbit [38]. Sulforaphane, mainly derived from
cruciferous vegetables, inhibited the expression of iNOS that
had been stimulated by LPS in HUVECs [39]. Together, these
results show that flavonoids have a common inhibitory effect
on iNOS expression in a number of different cell types in
a variety of conditions.
To understand the mechanisms for EGCG attenuation of
iNOS expression by angiotensin II, we examined that ROS
attenuation in HUVECs induced by EGCG led to an inhibition
of iNOS expression. Our data demonstrate that EGCG
increases ROS and does not affect ROS increased by
angiotensin II (Figure 3). EGCG triggered ROS resulted in
chondrosarcoma cell death [40]. However, EGCG decreased
the angiotensin II-induced increase of O2
− and ROS in vascular
smooth muscle cells [41]. Therefore, interference with ROS
production by EGCG may be different in different cell types
and under a variety of conditions. Alternatively, overproduction
of ROS by EGCG might inhibit the expression of iNOS in
HUVECs.
In conclusion, the anti-atherosclerotic activity of EGCG is
likely not associated with decreased ROS production, although
there may be some benefit through inhibiting the expression
of iNOS induced by angiotensin II.
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